Protein kinase C-mediated acute tolerance to peripheral μ-opioid analgesia in the bradykinin-nociception test in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 293, Issue 2, 2000, Pages 662-669

  Inoue, Makoto ^a   Ueda, Hiroshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; ANTISENSE OLIGODEOXYNUCLEOTIDE; BRADYKININ; CALPHOSTIN C; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; KAPPA OPIATE RECEPTOR; KT 5720; LEUCINE ENKEPHALIN[2 DEXTRO SERINE 6 THREONINE]; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALOXONE; NORBINALTORPHIMINE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; DRUG TOLERANCE; ENZYME ACTIVATION; FLEXOR REFLEX; MALE; MOUSE; NERVE ENDING; NOCICEPTION; NONHUMAN; PLANTARIS MUSCLE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANALGESICS, OPIOID; ANIMALS; BENZENEACETAMIDES; BLOTTING, WESTERN; BRADYKININ; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, LEUCINE; ENZYME INHIBITORS; MALE; MICE; MORPHINE; NOCICEPTORS; OLIGONUCLEOTIDES, ANTISENSE; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM; PROTEIN KINASE C; PYRROLIDINES; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU;

EID: 0034011235     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Abdulla FA and Smith PA (1998) Axotomy reduces the effect of analgesic opioids yet increases the effect of nociceptin on dorsal root ganglion neurons. J Neurosci 18:9685-9694.
2. Cai YC, Ma L, Fan GH, Zhao J, Jiang LZ and Pei G (1997) Activaiton of N-methyl-D-aspartate receptor attenuates acute responsiveness of delta-opioid receptors. Mol Pharmacol 51:583-587.
3. Cesare P, Dekker LV, Sardini A, Parker PJ and McNaughton PA (1999) Specific involvement of PKC-epsilon in sensitization of the neuronal response to painful heat. Neuron 23:617-624.
4. Chien C-C, Brown G, Pan YX and Pasternak GW (1994) Blockade of U50,488H analgesia by antisense oligodeoxynucleotides to a kappa-opioid receptor. Eur J Pharmacol 253:R7-R8.
5. Coggeshall RE, Zhou S and Carlton SM (1997) Opioid receptors on peripheral sensory axons. Brain Res 764:126-132.
6. Dickenson AH, Oliveras JL and Besson JM (1979) Role of the nucleus raphe magunus in opiate analgesias studied by microinjection technique in the rat. Brain Res 170:95-111.
7. Hassan AH, Ableitner A, Stein C and Herz A (1993) Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience 55:185-195.
8. Hong Y and Abbott FV 11995) Peripheral opioid modulation of pain and inflammation in the formalin test. Eur J Pharmacol 277:21-28.
9. Hosobuchi Y, Adams JE and Linchitz R (1977) Pain relief by electrical stimulation of the central gray matter in humans and its reversal by naloxone. Science (Wash DC) 197:183-186.
10. Hylden JL and Wilcox GL (1980) Intrathecal morphine in mice: A new technique. Eur J Pharmacol 67:313-316.
11. Inoue M, Kobayashi M, Kozaki S, Zimmer A and Ueda H (1998a) Nociceptin/ orphanin FQ-induced nociceptive responses through substance P release from peripheral nerve endings in mice. Proc Natl Acad Sci USA 95:10949-10953.
12. Inoue M, Nakayamada H, Tokuyama S and Ueda H (1997) Peripheral non-opioid analgesic effects of kyotorphin in mice. Neurosci Lett 236:60-62.
13. Inoue M, Tokuyama S, Nakayamada H and Ueda H (1998b) In vivo signal transduction of tetrodotoxin-sensitive nociceptive response by substance P given into the plantar of mouse hind limb. Cell Mol Neurobiol 18:555-561.
14. Kashiwada Y, Huang L, Ballas LM, Jiang JB, Janzen WP and Lee KH (1994) New hexahydroxybiphenyl derivatives as inhibitors of protein kina. J Med Chem 37: 195-200.
15. Khasar SG, Gold MS, Dastmalchi S and Levine JD (1996) Selective attenuation of mu-opioid receptor-mediated effects in rat sensory neurons by intrathecal administration of antisense oligodeoxynucleotides. Neurosci Lett 218:17-20.
16. Khasar SG, Lin Y-H, Martin A, Dadgar J, McMahoh T, Wang D, Hundle B, Aley KO, Isenberg W, McCarter G, Green PG, Hodge CW, Levine JD and Messing RO (1999) A novel nociceptor signaling pathway revealed in protein kinase C ∈ mutant mice. Neuron 24:253-260.
17. Koch T, Schulz S, Schroder H, Wolf R, Raulf E and Hollt V (1998) Carboxyl-terminal splicing of the rat mu opioid receptor modulates agonist-mediated internalization and receptor resensitizalion. J Biol Chem 273:13652-13657.
18. Kolesnikov Y, Jain S, Wilson R and Pasternak GW (1996a) Peripheral kappa 1-opioid receptor-mediated analgesia in mice. Eur J Pharmacol 310:141-143.
19. Kolesnikov Y, Jain S, Wilson R and Pasternak GW (1996b) Peripheral morphine analgesia: Synergy with central sites and a target of morphine tolerance. J Pharmacol Exp Ther 279:502-506.
20. Kramer HK and Simon EJ (1999) Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: II. Activation and involvement of the alpha, epsilon, and zeta isoforms of PKC. J Neurochem 72:594-604.
21. Li JG, Luo LY, Krupnick JG, Benovic JL and Liu-Chen LY (1999) U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin-and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation. J Biol Chem 274:12087-12094.
22. Lu Z, Hornia A, Jiang YW, Zang Q, Ohno S and Foster DA (1997) Tumor promotion by depleting cells of protein kinase C delta. Mol Cell Biol 17:3418-3428.
23. Maekawa K, Minami M, Yabuuchi K, Toya T, Katao Y, Hosoi Y, Onogi T and Satoh M (1994) In situ hybridization study of mu-and kappa-opioid receptor mRNAs in the rat spinal cord and dorsal root ganglia. Neurosci Lett 168:97-100.
24. Min BH, Augustin LB, Felsheim R, Fuchs JA and Loh HH (1994) Genomic structure and analgesis of promoter sequence of a mouse μ opioid receptor gene. Proc Natl Acad Sci USA 91:9081-9085.
25. Narita M, Ohsawa M, Mizoguchi H, Kamei J and Tseng LF (1997) Pretreatment with protein kinase C activator phorbol 12,13-dibutyrate attenuates the antinociception induced by mu-but not epsilon-opioid receptor agonist in the mouse. Neuroscience 78:291-298.
26. Nestler EJ (1992) Molecular mechanisms of drug addiction. J Neurosci 12:2439-2450.
27. Nestler EJ, Alreja M and Aghajanian GK (1994) Molecular and cellular mechanisms of opiate action: Studies in the rat locus coeruleus. Brain Res Bull 35:521-528.
28. Nishizuka Y (1992) Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science (Wash DC) 258:607-614.
29. Schafer M, Imai Y, Uhl GR and Stein C (1995) Inflammation enhances peripheral mu-opioid receptor-mediated analgesia, but not mu-opioid receptor transcription in dorsal root ganglia. Eur J Pharmacol 279:165-169.
30. Schulz S, Schreff M, Koch T, Zimprich A, Gramsch C, Eide R and Hollt V (1998) Immunolocalization of two mu-opioid receptor isoforms (MOR1 and MOR1B) in the rat central nervous system. Neuroscience 82:613-622.
31. Sharma SK, Klee WA and Nirenberg M (1975) Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc Natl Acad Sci USA 72:3092-3096.
32. Stein C (1995) The control of pain in peripheral tissue by opioids. N Engl J Med 332:1685-1690.
33. Sternini C, Spann M, Anton B, Keith DE Jr, Bunnett NW, von Zastrow M, Evans C and Brecha NC (1996) Agonist-selective endocytosis of mu opioid receptor by neurons in vivo. Proc Natl Acad Sci USA 93:9241-9246.
34. Takagi H (1980) The nucleus reticularis paragiganto-cellularis as a site of analgesic action of morphine and enkephalin. Trends Pharmacol Sci 1:182-184.
35. Ueda H (1999) In vivo molecular signal transduction of peripheral mechanisms of pain. Jpn J Pharmacol 79:263-268.
36. i1-phospholipase C activation in Xenopus oocytes. J Neurosci 15:7485-7499.
37. 3-gated calcium transport through plasma membranes in nerve terminals. J Neurosci 16:2891-2900.
38. Wenzel-Seifert K, Schachtele C and Seifert R (1994) N-protein kinase C isoenzymes may be involved in the regulation of various neutrophil functions Biochem Biophys Res Commun 200:1536-1543.
39. Yeung JC and Rudy RA (1980) Multiplicative interaction between narcotic agonisms expressed at spinal and supraspinal sites of antinociceptive action as revealed by concurrent intrathecal and intracerebroventricular injections of morphine. J Pharmacol Exp Ther 215:633-642.
40. Yoshida A and Ueda H (1999) Activation of Gi1 by lysophosphatidic acid receptor without ligand in the baculovirus expression system. Biochem Biophys Res Commun 259:78-84.
41. Zhang J, Ferguson SS, Barak LS, Bodduluri SR, Laporte SA, Law PY and Caron MG (1998b) Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc Natl Acad Sci USA 95:7157-7162.
42. Zhang X, Bao L, Arvidsson U, Elde R and Hokfelt T (1998a) Localization and regulation of the delta-opioid receptor in dorsal root ganglia and spinal cord of the rat and monkey: Evidence for association with the membrane of large dense-core vesicles Neuroscience 82:1225-1242.
43. Zhou L, Zhang Q, Stein C and Schafer M (1998) Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia. J Pharmacol Exp Ther 286:1000-1006.
44. Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109-110.